Company
Sana Biotechnology
Engineered cells as medicines
Also known as Sana Biotechnology, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Sana Biotechnology, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Repairing and controlling genes in cells or replacing missing or damaged cells can solve the underlying cause of many diseases. These emerging capabilities will create novel medicines that meaningfully improve patient outcomes, and Sana aims to lead the way.
Funding snapshot
- Total raised
- $867MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $821M2019-02-13
Funding rounds
- Round, 2019
- $821M2019-02-13, SEC form D sold, 40 investors
- Round, 2018
- $45.9M2018-10-02, SEC form D sold, 8 investors
Loading relationship preview